Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reactions to infliximab.

• In: Hospital Pharmacy Section - Poster Session
• At: Salvadore (Brazil) (2006)
• Type: Poster
• Poster code: HPS-P-023
• By: AUGUSTSSON, Jenny (Apoteket AB, Stockholm, Sweden)
• Co-author(s): Ernestam, Sofia (Karolinska Institute, STOCKHOLM, Sweden)
  Eksborg, Staffan (Karolinska Institute, STOCKHOLM, Sweden)
  Van Vollenhoven, Ronald (Karolinska Institute, STOCKHOLM, Sweden)
  
• Abstract:

  Background:
  
  Infusion reactions are a well-described complication of infliximab (Remicade) therapy and represent the cause of appr. 15% of the discontinuations of this treatment. The aim of this study was to investigate the role of glucocorticoids and possible predictors of infusion reactions, thus improving the patient safety.
  
  
  
  Methods:
  
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login